Chris Hollowood has been the Chairman of SwanBio’s Board of Directors since 2018. He also serves as the Chief Investment Officer of Syncona Investment Management Limited, part of Syncona Limited, a leading healthcare investment company focused on founding, building, and funding global leaders in life sciences